SAFETY AND EFFICACY OF OSIMERTINIB AS A THERAPY IN PATIENTS WITH EGFR T790M POSITIVE NON SMALL CELL LUNG CANCER PATIENTS: A SYSTEMATIC REVIEW

被引：0
|
作者：
Gadi, H. R. [1 ]
Ganta, M. R. [1 ]
Voleti, V. B. [1 ]
Rayavarapu, J. E. [1 ]
Thatavarti, R. [1 ]
机构：
[1] Excelra Knowledge Solut, Hyderabad, Andhra Pradesh, India
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.119
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN37
引用
收藏
页码：A418 / A418
页数：1
相关论文
共 50 条
  • [41] Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial
    Kazuhisa Nakashima
    Yuichi Ozawa
    Haruko Daga
    Hisao Imai
    Motohiro Tamiya
    Takaaki Tokito
    Takahisa Kawamura
    Hiroaki Akamatsu
    Yuko Tsuboguchi
    Toshiaki Takahashi
    Nobuyuki Yamamoto
    Keita Mori
    Haruyasu Murakami
    [J]. Investigational New Drugs, 2020, 38 : 1854 - 1861
  • [42] Detect T790M in cell free tumor DNA of Chinese advanced non-small cell lung cancer adenocarcinoma patients by different platforms and evaluate clinical outcomes of T790M positive patients with osimertinib monotherapy
    Liang, Zhiyong
    Cheng, Ying
    Chen, Yuan
    Liu, Weiping
    Lu, You
    Wang, Jie
    Wu, Gang
    Ying, Jian-Ming
    Zhang, Xu-Chao
    Wu, Yi-Long
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [43] Survival benefit of osimertinib combination therapy in patients with T790M-positive non-small-cell lung cancer refractory to osimertinib treatment
    Su, Po-Lan
    Tsai, Jeng-Shiuan
    Yang, Szu-Chun
    Wu, Yi-Lin
    Tseng, Yau-Lin
    Chang, Chao-Chun
    Yen, Yi-Ting
    Lin, Chia-Ying
    Lin, Chien-Chung
    Wang, Chin-Chou
    Lin, Meng-Chih
    Su, Wu-Chou
    [J]. LUNG CANCER, 2021, 158 : 137 - 145
  • [44] Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial
    Nakashima, Kazuhisa
    Ozawa, Yuichi
    Daga, Haruko
    Imai, Hisao
    Tamiya, Motohiro
    Tokito, Takaaki
    Kawamura, Takahisa
    Akamatsu, Hiroaki
    Tsuboguchi, Yuko
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    Mori, Keita
    Murakami, Haruyasu
    [J]. INVESTIGATIONAL NEW DRUGS, 2020, 38 (06) : 1854 - 1861
  • [45] High ratio of T790M to EGFR activating mutations correlate with the osimertinib response in non-small-cell lung cancer
    Ariyasu, Ryo
    Nishikawa, Shingo
    Uchibori, Ken
    Oh-hara, Tomoko
    Yoshizawa, Takahiro
    Dotsu, Yosuke
    Koyama, Junji
    Saiki, Masafumi
    Sonoda, Tomoaki
    Kitazono, Satoru
    Yanagitani, Noriko
    Horiike, Atsushi
    Inase, Naohiko
    Kasahara, Kazuo
    Nishio, Makoto
    Katayama, Ryohei
    [J]. LUNG CANCER, 2018, 117 : 1 - 6
  • [46] The impact of EGFR T790M mutation status following the development of Osimertinib resistance on the efficacy of Osimertinib in non-small cell lung cancer: A meta-analysis
    Guo, Liuxian
    Zhou, Guojin
    Huang, Min
    Tang, Kejing
    Xu, Jing
    Chen, Jie
    [J]. CLINICAL RESPIRATORY JOURNAL, 2024, 18 (04):
  • [47] Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer
    Stratmann, Jan A.
    Michels, Sebastian
    Hornetz, Sofia
    Christoph, Daniel C.
    Sackmann, Sandra
    Spengler, Werner
    Bischoff, Helge
    Schaefer, Monica
    Alt, Juergen
    Mueller, Annette
    Laack, Eckart
    Kimmich, Martin
    Griesinger, Frank
    Sebastian, Martin
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (12) : 2457 - 2463
  • [48] The correlation between the abundance of EGFR T790M mutation and osimertinib response in advanced non-small cell lung cancer
    Pan, Guoqiang
    Chen, Kaiyan
    Yu, Xiaoqing
    Sheng, Jiamin
    Fan, Yun
    [J]. TRANSLATIONAL CANCER RESEARCH, 2021, 10 (06) : 2895 - 2905
  • [49] Genomic Profiling of EGFR T790M Mutated Non-Small Cell Lung Cancer to Evaluate the Mechanisms of Resistance to Osimertinib
    Puri, S.
    Hicks, J.
    Knepper, T.
    Smith, M.
    Boyle, T.
    Gray, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1848 - S1849
  • [50] Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer
    Jan A. Stratmann
    Sebastian Michels
    Sofia Hornetz
    Daniel C. Christoph
    Sandra Sackmann
    Werner Spengler
    Helge Bischoff
    Monica Schäfer
    Jürgen Alt
    Annette Müller
    Eckart Laack
    Martin Kimmich
    Frank Griesinger
    Martin Sebastian
    [J]. Journal of Cancer Research and Clinical Oncology, 2018, 144 : 2457 - 2463
12345